TERT and metastatic neoplasm: In conclusion, as HPV status, integration status, TERT promoter mutations, and mutational profiling are not significantly correlated to PFS and/or OS in this study, DCF chemotherapy should be proposed to all SCCA patients failing radio-chemotherapy (CRT) or with metastatic disease.